NCT06473623Recruiting
Non-invasive Auricular Fiber Vagus Nerve Stimulation (afVNS) for Treatment of Autism Spectrum Disorder
Non-invasive Auricular Fiber Vagus Nerve Stimulation (afVNS) for Treatment of Autism Spectrum Disorder: An Open-Label Trial
Source: ClinicalTrials.gov · Last updated 8 Jan 2026
Brief summary (registry, in English)
Non-invasive vagus nerve stimulation for the symptomatic improvements in Autism Spectrum Disorder
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 19 Jun 2024
- Start date
- 1 Dec 2025
- Primary completion date
- 1 Feb 2026
- Lead sponsor
- Neuropix
- Diseases
- Autism
- NCT number
- NCT06473623
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 1 Dec 2025 to the primary completion date, 1 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Active medical implants (cochlear, VNS or pacemakers)
Other illness
- Severe psychiatric disorders (e.g. bipolar, major depressive disorder)
- Severe neurological disorders (e.g. stroke, epilepsy)
- History of head trauma (surgery or tumor)
- Auricular skin disease that compromises placement of electrodes
Other
- Bradyarrhythmia
- Cerebral shunts
- Pregnancy
Who the study is looking for
- Written informed consent
- Age: between 7 and 26 years
- Participants and parent/ guardian must have proficiency in English
- Diagnosis of ASD as defined by ADOS-2 or DSM-5 criteria
Age in the registry: 7 years to 26 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hong Kong Science Park Coordinator of this site? Confirm its status | Tai Po | Hong Kong | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.